Abstract
Anxiolytic benzodiazepines are used in the treatment of anxiety. Nonmedical use has widely developed, mainly because of their ability to generate addiction. Main indications are anxiety disorders with or without depressive symptoms. Action mechanisms include complex interaction with GABA-receptor. Dependence, tolerance and withdrawal are well-known. Treatment of substance abuse is given. Main non-benzodiazepine alternate treatments of anxiety disorders are proposed.
MeSH terms
-
Anti-Anxiety Agents / adverse effects
-
Anti-Anxiety Agents / therapeutic use*
-
Anxiety Disorders / drug therapy*
-
Anxiety Disorders / physiopathology
-
Anxiety Disorders / psychology
-
Brain / drug effects*
-
Brain / physiopathology
-
Depressive Disorder / drug therapy
-
Depressive Disorder / physiopathology
-
Depressive Disorder / psychology
-
Humans
-
Neurotransmitter Agents / physiology
-
Receptors, GABA-A / drug effects*
-
Receptors, GABA-A / physiology
-
Substance-Related Disorders / etiology*
-
Substance-Related Disorders / physiopathology
-
Substance-Related Disorders / rehabilitation
Substances
-
Anti-Anxiety Agents
-
Neurotransmitter Agents
-
Receptors, GABA-A